Mercury Acquisitions Corp. Announces Results of Special Meeting

Written by Customer Service on September 21, 2021. Posted in Public Companies.

TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Mercury Acquisitions Corp. (the “Company” or “Mercury”) (TSXV: MERC.P) is pleased to announce shareholders of the Company approved all of the matters brought before them by the requisite majorities at the special meting of shareholders held on September 20, 2021 (the “Meeting”) as set out in the management information circular dated August 16, 2021. At the Meeting, it was resolved that upon the completion of the proposed qualifying transaction with Franchise Cannabis Corp. (the “Effective Time”): (i) the number of directors of the Company shall be fixed to five (5) members; (ii) Clifford Starke, Larry W. Smith, Peter Simeon, Jakub Malczewski, and Farhan Lalani shall be the directors of the Company; (iii) MNP LLP shall be the auditor of the Company; (iv) the Company’s stock option plan...

Kimball Electronics to Participate at the Sidoti Fall 2021 Virtual Investor Conference

Written by Customer Service on September 21, 2021. Posted in Public Companies.

Company Reaffirms Guidance With Supply Chain Disruptions Shifting More Shippable Backlog to Second Half of Fiscal 2022 JASPER, Ind., Sept. 21, 2021 (GLOBE NEWSWIRE) — Kimball Electronics, Inc. (Nasdaq: KE) today announced the company will be attending the Sidoti Fall 2021 Virtual Investor Conference. Donald D. Charron, Chairman and Chief Executive Officer, and Jana Croom, Vice President, Chief Financial Officer, will participate in a fireside chat on Thursday, September 23, 2021 at 10:00 AM ET. A webcast of the fireside chat will be available on the company website, on the Events & Presentations tab in the Investor Relations section, at https://investors.kimballelectronics.com/events-presentations. If you are unable to attend the live webcast, an archive will be available in this same location on the company website. In advance...

Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footprint in Seattle

Written by Customer Service on September 21, 2021. Posted in Public Companies.

New Partnership with Youth Organization STEM Paths Innovation Network (SPIN) Seeds Next Generation of Local Biotech Talent SEATTLE, Sept. 21, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced today the opening of its new corporate headquarters and laboratory facility located in the heart of South Lake Union – Seattle’s life sciences hub. “Washington is proud to be home to companies like Adaptive that are changing the future of medicine,” said keynote speaker Gov. Jay Inslee. “Our thriving life sciences community is world-class and will benefit our state and our world for generations. I am glad their new corporate headquarters and lab...

Isoray Announces Fourth Quarter and Full-Year Fiscal Year End 2021 Financial Results

Written by Customer Service on September 21, 2021. Posted in Earnings Releases And Operating Results.

Record Full Year RevenueFiscal Fourth Quarter Revenue Increased 19% Year-Over-Year RICHLAND, Wash., Sept. 21, 2021 (GLOBE NEWSWIRE) — Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced financial results for the fiscal fourth quarter and full-year ended June 30, 2021. Revenue for the fourth quarter of fiscal 2021 grew 19% to $2.71 million versus $2.28 million in the prior year comparable period. The Company’s core prostate brachytherapy revenue grew 5% when compared to the fiscal fourth quarter of 2020. Prostate brachytherapy represented 74% of total revenue for the fourth quarter of fiscal 2021 compared to 84% in the prior year comparable period. Record non-prostate brachytherapy revenue increased 92% versus...

InnovAge Announces Financial Results for the Fiscal Year and Fourth Quarter Ended June 30, 2021

Written by Customer Service on September 21, 2021. Posted in Earnings Releases And Operating Results.

DENVER, Sept. 21, 2021 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced financial results for its fiscal fourth quarter and full year ended June 30, 2021. “The InnovAge team is excited to deliver strong fourth quarter financial results to end the year with approximately 6,850 participants, an increase of 7.4% year-over-year,” said Maureen Hewitt, President and Chief Executive Officer, of InnovAge. “We produced $637.8 million of total revenues, an increase of approximately 12.5% compared to fiscal year 2020. During the pandemic, we opened two new centers and we remain on track to open de novo centers in two new states in fiscal year 2023. We also expanded our leadership team with the additions of Nicole...

Stitch Fix Announces Fourth Quarter and Full Fiscal Year 2021 Financial Results

Written by Customer Service on September 21, 2021. Posted in Earnings Releases And Operating Results.

SAN FRANCISCO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal shopping and styling service, has released its financial results for the fourth quarter and full fiscal year 2021 ended July 31, 2021. Stitch Fix CEO Elizabeth Spaulding said, “In Q4 we delivered $571 million in net revenue, reflecting 29% year-over-year growth, helping us cross $2 billion in annual net revenue for the first time. These results reflect strong performance across our business, in Women’s, Kids and the UK. Today, we are proud to serve almost 4.2 million clients, and with the launch of Stitch Fix Freestyle in August we are significantly increasing our addressable market and we’re energized by the opportunity ahead. As we look forward, we are focused on continuing to expand and transform our offering, and drive...

Brilliant Acquisition Corporation Announces Extension of Completion Window to December 25, 2021

Written by Customer Service on September 21, 2021. Posted in Public Companies.

New York, Sept. 21, 2021 (GLOBE NEWSWIRE) — Brilliant Acquisition Corporation (the “Company”) announced today that it has extended the period of time it will have to consummate its initial business combination by 3 months from the current deadline of September 25, 2021 until December 25, 2021 (the “completion window”) because the Company’s Sponsor, Nisun Investment Holding Limited has timely deposited $460,000 in the Company’s trust account, representing $0.10 per Unit as additional interest on the proceeds in the trust account, pursuant to the terms of the Company’s amended and restated memorandum and articles of association, and the trust agreement entered into between the Company and Continental Stock Transfer & Trust Company. About the Company Brilliant Acquisition Corporation is a blank check company organized for the...

Inventiva announces FDA decision that Fast Track designation granted to lanifibranor in NASH encompasses the treatment of NASH with compensated cirrhosis

Written by Customer Service on September 21, 2021. Posted in Public Companies.

The FDA decision follows the Company’s Fast Track designation request for lanifibranor in NASH with compensated cirrhosis filed in August 2021 Daix (France), Long Island City (New York, United States), September 21, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has decided that the Fast Track designation previously granted to lanifibranor in NASH encompasses the treatment of NASH patients with compensated cirrhosis. This decision follows a Fast Track designation request for lanifibranor in NASH with compensated cirrhosis filed...

Selectis Health Announces Effective Date of Reverse Stock Split and Name Change

Written by Customer Service on September 21, 2021. Posted in Public Companies.

Common Stock Will Begin Trading with its new name and on a Split-Adjusted Basis on September 22, 2021 GREENWOOD VILLAGE, Colorado, Sept. 21, 2021 (GLOBE NEWSWIRE) — Selectis Health, Inc. (formerly Global Healthcare REIT, Inc.) (the “Company” or “Selectis”), announced today that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split share (the “Reverse Split”). Selectis’ common stock will continue to be traded on the OTC.Pink of the OTC Markets Group, Inc. under the ticker symbol GBCS and will begin trading on a split-adjusted basis when the market opens on Wednesday, September 22, 2021, (the “Effective Date”) under a new CUSIP number 816291108. For a period of 20 business days, a “D” will be placed on the Company’s ticker symbol to reflect the Reverse Split. Also on...

AllStar Health Shareholder Update

Written by Customer Service on September 21, 2021. Posted in Public Companies.

MIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) — AllStar Health Brands (OTC Pink: ALST) has opted to issue a shareholder update as there are a number of initiatives that are now coming to fruition. ALST has formed a strategic partnership with Virotek Biosciences Inc., to facilitate the application of the rapid COVID test to the various AllStar commercial, industrial and civic customers. Agreeing to regular testing appears to be one of the alternatives that some employers will accept in place of double dose vaccine. This opens the way for services such as the ALST- Virotek partnership to complete those tests. The Company has also entered into the testing phase of the new web site https://vividcbd.com/. We have secured a contracted supply of the product, we have the rights to expand into other product lines, and we have the systems in place...

Day: September 21, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice